SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $46,902,000 | +1.4% | 46,902,000 | 0.0% | 3.79% | -5.0% |
Q4 2022 | $46,257,098 | +0.9% | 46,902,000 | 0.0% | 3.99% | -6.0% |
Q3 2022 | $45,824,000 | +0.2% | 46,902,000 | 0.0% | 4.24% | -3.5% |
Q2 2022 | $45,737,000 | -1.5% | 46,902,000 | 0.0% | 4.40% | +17.6% |
Q1 2022 | $46,433,000 | +2.8% | 46,902,000 | +3.3% | 3.74% | +9.2% |
Q4 2021 | $45,147,000 | +0.7% | 45,402,000 | 0.0% | 3.42% | -18.6% |
Q3 2021 | $44,828,000 | +21.0% | 45,402,000 | +21.6% | 4.21% | +5.9% |
Q2 2021 | $37,062,000 | +2.0% | 37,347,000 | 0.0% | 3.97% | -10.4% |
Q1 2021 | $36,345,000 | -1.7% | 37,347,000 | -3.7% | 4.44% | +7.7% |
Q4 2020 | $36,963,000 | -4.5% | 38,801,000 | -7.2% | 4.12% | -13.0% |
Q3 2020 | $38,713,000 | +3.6% | 41,818,000 | +99876.1% | 4.74% | -25.8% |
Q2 2020 | $37,385,000 | +10.9% | 41,828 | +2.0% | 6.39% | -7.6% |
Q1 2020 | $33,718,000 | +287.5% | 41,026 | +329.1% | 6.91% | +427.8% |
Q4 2019 | $8,701,000 | – | 9,562 | – | 1.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 46,902,000 | $45,737,000 | 4.40% |
INCOME RESEARCH & MANAGEMENT | 7,500,000 | $7,280,000 | 3.12% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $94,477,000 | 2.13% |
PIPER SANDLER & CO. | 2,200,000 | $2,112,000 | 1.92% |
DeepCurrents Investment Group LLC | 41,092,000 | $39,934,000 | 1.59% |
Radcliffe Capital Management, L.P. | 69,010,000 | $66,983,000 | 1.54% |
Sonora Investment Management Group, LLC | 9,635,000 | $9,389,000 | 0.89% |
Penn Mutual Asset Management | 675,000 | $656,000 | 0.88% |
OAKTREE CAPITAL MANAGEMENT LP | 24,447,000 | $23,851,000 | 0.28% |
WOLVERINE ASSET MANAGEMENT LLC | 8,681,000 | $8,429,000 | 0.08% |